These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


201 related items for PubMed ID: 38941573

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [The role of aquaporin 4 antibody in the injury of retinal microstructure in neuromyelitis optica spectrum disorders].
    Wang ZW, Wang QQ, Diao DW, Guo QF, Qi XK.
    Zhonghua Nei Ke Za Zhi; 2018 Jun 01; 57(6):435-439. PubMed ID: 29925129
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Retina thickness in clinically affected and unaffected eyes in patients with aquaporin-4 immunoglobulin G antibody seropositive neuromyelitis optica spectrum disorders: a systematic review and meta-analysis.
    Huang L, Wang Y, Zhang R.
    J Neurol; 2023 Feb 01; 270(2):759-768. PubMed ID: 36355186
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Altered fovea in AQP4-IgG-seropositive neuromyelitis optica spectrum disorders.
    Motamedi S, Oertel FC, Yadav SK, Kadas EM, Weise M, Havla J, Ringelstein M, Aktas O, Albrecht P, Ruprecht K, Bellmann-Strobl J, Zimmermann HG, Paul F, Brandt AU.
    Neurol Neuroimmunol Neuroinflamm; 2020 Sep 01; 7(5):. PubMed ID: 32576604
    [Abstract] [Full Text] [Related]

  • 13. High resolution retinal scanning reveals regional structural differences between MS and NMOSD optic neuritis regardless of antibody status.
    Bertsch-Gout M, Loeb R, Finch AK, Javed A, Bernard J.
    J Neurol Sci; 2018 Jan 15; 384():61-66. PubMed ID: 29249380
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Foveal changes in aquaporin-4 antibody seropositive neuromyelitis optica spectrum disorder are independent of optic neuritis and not overtly progressive.
    Roca-Fernández A, Oertel FC, Yeo T, Motamedi S, Probert F, Craner MJ, Sastre-Garriga J, Zimmermann HG, Asseyer S, Kuchling J, Bellmann-Strobl J, Ruprecht K, Leite MI, Paul F, Brandt AU, Palace J.
    Eur J Neurol; 2021 Jul 15; 28(7):2280-2293. PubMed ID: 33547839
    [Abstract] [Full Text] [Related]

  • 16. Use of retinal optical coherence tomography to differentiate suspected neuromyelitis optica spectrum disorder from multiple sclerosis: A cross-sectional study.
    Ayoubi NKE, Moussa H, Younes A, Haddad R, Khoury SJ.
    Mult Scler Relat Disord; 2022 Dec 15; 68():104160. PubMed ID: 36113276
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Myelin-oligodendrocyte-glycoprotein (MOG) autoantibodies as potential markers of severe optic neuritis and subclinical retinal axonal degeneration.
    Havla J, Kümpfel T, Schinner R, Spadaro M, Schuh E, Meinl E, Hohlfeld R, Outteryck O.
    J Neurol; 2017 Jan 15; 264(1):139-151. PubMed ID: 27844165
    [Abstract] [Full Text] [Related]

  • 19. Optic chiasm involvement in multiple sclerosis, aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein-associated disease.
    Bianchi A, Cortese R, Prados F, Tur C, Kanber B, Yiannakas MC, Samson R, De Angelis F, Magnollay L, Jacob A, Brownlee W, Trip A, Nicholas R, Hacohen Y, Barkhof F, Ciccarelli O, Toosy AT.
    Mult Scler; 2024 May 15; 30(6):674-686. PubMed ID: 38646958
    [Abstract] [Full Text] [Related]

  • 20. Retinal Morphology and Sensitivity Are Primarily Impaired in Eyes with Neuromyelitis Optica Spectrum Disorder (NMOSD).
    Akiba R, Yokouchi H, Mori M, Oshitari T, Baba T, Sawai S, Kuwabara S, Yamamoto S.
    PLoS One; 2016 May 15; 11(12):e0167473. PubMed ID: 27936154
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.